Dr. Pieter Cullis
-
As of March 2024, the university has raised more than $33.4 million towards its goal of $100 million for the Student Affordability Initiative through FORWARD, the fundraising campaign for UBC.
-
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
When the next pandemic hits, Canada will be better prepared to respond with homegrown vaccines and therapeutics.
-
Dr. Pieter Cullis named 2022 Canada Gairdner Award laureate
UBC professor Dr. Pieter Cullis has been named a 2022 Canada Gairdner International Award laureate for his pioneering work developing the lipid nanoparticle delivery technology that enables mRNA therapeutics such as the highly effective COVID-19 mRNA vaccines.
-
UBC-grown biotech companies lead global pandemic efforts
Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC.
